Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 21, 2014; 20(23): 7181-7196
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7181
Table 1 Nucleotide divergence over the complete genome among hepatitis B virus genotypes F and H
ClusterHMEXHUSAHSAHnon-Hispanic
F1a8.638.898.708.51
(8.11-9.9)(8.16-9.5)(8.5-8.8)(8.22-8.91)
F1b8.638.888.598.49
(8.22-10.1)(8.04-9.86)(8.19-9.39)(8.04-9.31)
F28.078.838.777.9
(7.59-9.66)(8.04-9.86)(8.09-8.24)(7.66-8.48)
F37.847.767.947.69
(7.17-9.91)(7.28-8.94)(7.24-8.97)(7.24-8.82)
F48.368.668.508.29
(7.77-10.40)(7.84-9.98)(8.06-9.34)(7.91-9.33)
Table 2 Hepatitis B virus genotypes, clinical and serological characteristics and type of liver damage in South America n (%)
Ref.CountryStudy populationnHBsAg
Anti-HBc
HBV genotypes1
Diagnosis
PositiveABCDFGH
Cortes-Mancera et al[130], 2011ColombiaPatients with end-stage liver disease13114 (11)6 (5)----7 (100)--Cirrhosis in 71%
F1a, F3HCC in 12%;
Cirrhosis and HCC in 17%
Devesa et al[131], 2008HBV-infected patients100NANA2 (2)-2 (2)8 (8)86 (86)2 (2)-NA
F3
Alvarado Mora et al[58], 2011Blood donors143143 (100)NA8 (15)---40 (77)8 (15)-NA
Nakano et al[134], 2001VenezuelaAmerindian1212 (100)NA----12 (100)--CH in 33%
Quintero et al[132], 2002Afro-Venezuelan2228 (4)NA3 (50)---3 (50)--CH in 100%
Gutierrez et al[138], 2004Blood donors2582 (0.8)258 (100)1 (9)--7 (64)3 (27)--OHB in 4.3%; Rare severe liver disease
Kato et al[123], 2005HBV-infected patients2NANA----2 (100)--AH in 100%
F1
Devesa et al[131], 2008Amerindian89NANA3 (3)--5 (6)81 (91)--NA
F1; F2a; F2b; F3
Cardona et al[135], 2011Amerindian702 (3)25 (36)----25 (100)--OHB in 34%;
F3
Palumbo et al[133], 2007EcuadorImmigrants in Italy22 (100)0 (0)2 (100)------CH in 100%
Casey et al[139], 1996PeruMilitary personnel8477 (88)84 (95)----15 (100)--CH in 68%
Von Meltzer et al[140], 2008HBV-infected patients99 (100)NA----9 (9)--CH in 100%
F1b
Sitnik et al[143], 2004BrazilHBV-infected patients103103 (100)NA51 (49)3 (3)14 (14)25 (24)10 (10)--CH in 100%
Palumbo et al[133], 2007Immigrants in Italy1212 (100)0 (0)3 (25)--9 (75)---CH in 100%
Bertolini et al[144], 2012Blood donors228228 (100)NA32 (14)-3 (1)189 (83)3 (1)-1 (0.4)NA
A1, A2F2a, F4
Mello et al[102], 2013HBV-infected patients12NANA----12 (100) F2a, F1b, F4--NA
Eloy et al[145], 2013HBV-infected patients11980 (100)80 (100)74 (92)-4 (5)1 (1)1 (1)--Asymp in 70; AH in 2%; CH in 28%
Araujo et al[146], 2013HBV/HIV-coinfected patients11 (100)1 (100)----1 (100)1-CH in 100%
F4-100
Khan et al[147], 2008BoliviaJapanese immigrants28710 (8)NA-1 (1)5 (50)-4 (4)--NA
BaC2
Khan et al[147], 2008Native population20012 (6)NA-1 (8)3 (25)-8 (68); F4--NA
Di Lello et al[141], 2009,ChileHBV-infected patients40NANA3 (7)2 (5)3 (7)-27 (67)--NA
Venegas et al[142],2011HBV-infected patients2121 (100)21 (100)----21 (100)--CH in 100%
F1b
Solari et al[149], 2009ArgentinaHBV-infected patients2121 (100)-8 (38)3 (14)-3 (14)7 (33)--CH in 100%
Pezzano et al[150], 2011HBV-infected patients139128 (100)128 (100)22 (28)1 (0.8)3 (2)28 (22)60 (47)--AH in 37%; CH in 63%
Trinks et al[148], 2012HBV-infected patients3333 (100)33 (100)15 (45) A1, A2--2 (6)13 (39)--CH in 100%
D1F1b, F4
Barbini et al[101], 2013HBV-infected patients2929 (100)29 (100)4 (14) A2--2 (7) D2, D320 (62)2 (7)-CH in 100%
F1b, F4
Araujo et al[146], 2013HBV/HIV-coinfected patients11 (100)1 (100)----1 (100); F1b1-CH in 100%
-100
Table 3 Hepatitis B virus genotypes, clinical and serological characteristics and type of liver damage in Mexico and Central America n (%)
Ref.CountryStudy populationnHBsAg
Anti-HBc
HBV genotypes1
Diagnosis
PositiveABCDEFGH
Sanchez et al[107], 2002MexicoHBV-infected adults1513 (87)6 (40)3 (20)--1 (7)-10 (67)1 (7)-AH in 30%;
CH in 27%;
cirrhosis in 7%.
Sanchez et al[50], 2007HBV-infected patients6767 (100)NA10 (15)--4 (6)4 (6)44 (66)AH in 15%;
CH in 48%
Ruiz-Tachiquin et al[151], 2007Blood donors and HBV-infected patients3333 (100)NA--4 (12)1 (3)-26 (79)Asymp in 64%; CH in 36%
Roman et al[98], 2010Native adults30617 (5.6)100 (32.7)6 (24)1 (4)2 (8)4 (16)-1 (4)11 (44)OHB in 14.2%; asymp in 100%
Arauz-Ruiz et al[115], 1997Central America:HBV-infected patients, blood donors and pregnant woman330330 (100)71 (21)13 (14)-1 (1)5 (6)71 (79)-CH in 21%;
Costa Rica, Nicaragua,F1a; F1b; F2AH in 16%
Honduras, El Salvador, Guatemala
Leon et al[122], 2005Costa RicaHBV-infected patients5032 (64)18 (36)---2 (4)-48 (96)-CH in 47%;
HCC in 16%
Kato et al[123], 2005PanamaHBV-infected patients2NANA----2 (100)--NA
F1, F3
Martinez et al[124], 2013Chinese residents32042 (13)-11 (61)7 (39)-----No evident liver disease
B2C1
Andernach et al[125], 2009HaitíPregnant woman320320 (100)128 (71)--40 (22)11 (6)---NA
A1, A2, A5D3, D4
Couto et al[126], 2013Haitian’s in South Florida27NANA---19 (79)----NA